Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AtriCure hails first-in-man implant of left atrial appendage occluder:

This article was originally published in Clinica

Executive Summary

AtriCure has, for the first time, implanted its CosGrove-Gillinov left atrial appendage (LAA) occlusion system into a patient. The LAA is a thumb-shaped area of the atrium that is prone to developing blood clots which can then migrate to other parts of the body. The product is a clip device designed to be implanted from outside the heart, thus avoiding contact with circulating blood and eliminating blood flow between the LAA and atria. Research has suggested that patients with atrial fibrillation are particularly prone to clot formation in the LAA, which some physicians believe is associated with AF-related strokes, claimed the West Chester, Ohio firm. The device was implanted during an open heart procedure by a team of doctors from the University of Zurich in Switzerland and Cleveland Clinic in Ohio.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049706

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel